Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma

Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma

Purpose For bone metastasis from hepatocellular carcinoma (HCC), radiotherapy (RT) has been used a palliative treatment with little impact on survival. Currently, ablative RT is popularly used, and a more than palliative effect is expected. Herein, we investigated the clinical efficacy of ablative R...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cancer research and clinical oncology 2021-09, Vol.147 (9), p.2693-2700
Hauptverfasser: Kim, Tae Hyung, Park, Sangjoon, Rim, Chai Hong, Choi, Chiwhan, Seong, Jinsil
Format: Artikel
Sprache:eng
Schlagworte:
Cancer Research
Hematology
Hepatocellular carcinoma
Internal Medicine
Liver cancer
Medical prognosis
Medicine
Medicine & Public Health
Metastases
Metastasis
Oncology
Original Article – Clinical Oncology
Pain
Palliation
Patients
Radiation therapy
Survival
α-Fetoprotein
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose For bone metastasis from hepatocellular carcinoma (HCC), radiotherapy (RT) has been used a palliative treatment with little impact on survival. Currently, ablative RT is popularly used, and a more than palliative effect is expected. Herein, we investigated the clinical efficacy of ablative RT in patients with bone metastasis from HCC. Methods In total, 530 patients with 887 lesions treated in 1992–2019 were reviewed. Oligometastasis was defined as the presence of 
ISSN:0171-5216
1432-1335
DOI:10.1007/s00432-021-03553-2